<SEC-DOCUMENT>0001104659-17-031616-index.html : 20170510 <SEC-HEADER>0001104659-17-031616.hdr.sgml : 20170510 <ACCEPTANCE-DATETIME>20170510170041 ACCESSION NUMBER: 0001104659-17-031616 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20170510 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 17831334 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a17-12882_18k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a17-12882_18k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>a17-12882_1ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: a17-12882_1ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g128821mm01i001.gif <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: g128821mm01i001.gif
</DOCUMENT> </SEC-DOCUMENT>